Assessment of Non-Occupational 1,4-Dioxane Exposure Pathways from Drinking Water and Product Use.


Journal

Environmental science & technology
ISSN: 1520-5851
Titre abrégé: Environ Sci Technol
Pays: United States
ID NLM: 0213155

Informations de publication

Date de publication:
19 04 2022
Historique:
pubmed: 6 4 2022
medline: 21 4 2022
entrez: 5 4 2022
Statut: ppublish

Résumé

1,4-Dioxane is a persistent and mobile organic chemical that has been found by the United States Environmental Protection Agency (USEPA) to be an unreasonable risk to human health in some occupational contexts. 1,4-Dioxane is released into the environment as industrial waste and occurs in some personal-care products as an unintended byproduct. However, limited exposure assessments have been conducted outside of an occupational context. In this study, the USEPA simulation modeling tool, Stochastic Human Exposure and Dose Simulator-High Throughput (SHEDS-HT), was adapted to estimate the exposure and chemical mass released down the drain (DTD) from drinking water consumption and product use. 1,4-Dioxane concentrations measured in drinking water and consumer products were used by SHEDS-HT to evaluate and compare the contributions of these sources to exposure and mass released DTD. Modeling results showed that compared to people whose daily per capita exposure came from only products (2.29 × 10

Identifiants

pubmed: 35380802
doi: 10.1021/acs.est.1c06996
pmc: PMC9364908
mid: NIHMS1826156
doi:

Substances chimiques

Dioxanes 0
Drinking Water 0
Organic Chemicals 0
Water Pollutants, Chemical 0
1,4-dioxane J8A3S10O7S

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

5266-5275

Subventions

Organisme : Intramural EPA
ID : EPA999999
Pays : United States

Références

Toxicol Appl Pharmacol. 1976 Dec;38(3):643-6
pubmed: 1014018
Sci Total Environ. 2017 Oct 15;596-597:236-245
pubmed: 28433766
Integr Environ Assess Manag. 2016 Oct;12(4):782-92
pubmed: 27156081
Water Res. 2014 Jan 1;48:406-19
pubmed: 24200013
J Chromatogr A. 2019 Dec 6;1607:460400
pubmed: 31405575
Arch Toxicol. 2016 Jun;90(6):1315-24
pubmed: 26223317
Environ Sci Technol. 2014 Nov 4;48(21):12750-9
pubmed: 25222184
Environ Sci Technol. 2016 Mar 1;50(5):2246-54
pubmed: 26829406
Integr Environ Assess Manag. 2013 Oct;9(4):554-9
pubmed: 23713009

Auteurs

Daniel Dawson (D)

Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, United States.

Hunter Fisher (H)

Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, United States.
Oak Ridge Institutes for Science and Education, Oak Ridge, Tennessee 37830, United States.

Abigail E Noble (AE)

Safer Consumer Products Program, California Department of Toxic Substances Control, 1001 I Street, Sacramento, California 95814, United States.

Qingyu Meng (Q)

Safer Consumer Products Program, California Department of Toxic Substances Control, 1001 I Street, Sacramento, California 95814, United States.

Anne Cooper Doherty (AC)

Safer Consumer Products Program, California Department of Toxic Substances Control, 1001 I Street, Sacramento, California 95814, United States.

Yuko Sakano (Y)

Safer Consumer Products Program, California Department of Toxic Substances Control, 1001 I Street, Sacramento, California 95814, United States.

Daniel Vallero (D)

Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, United States.

Rogelio Tornero-Velez (R)

Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, United States.

Elaine A Cohen Hubal (EA)

Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH